Caisse De Depot Et Placement Du Quebec Gilead Sciences, Inc. Transaction History

Caisse De Depot Et Placement Du Quebec

$53.5 Billion
Q3 2025

A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 1,271,032 shares of GILD stock, worth $158 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

1,271,032

Previous 1,369,433 7.19%

Holding current value

$158 Million

Previous $152 Million 7.08%

% of portfolio

0.26%

Previous 0.33%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$108.22 - $120.47 $10.6 Million - $11.9 Million	-98,401 Reduced 7.19%	1,271,032 $141 Million
Q2 2025 Aug 14, 2025	SELL	$96.91 - $113.0 $17.2 Million - $20.1 Million	-177,865 Reduced 11.5%	1,369,433 $152 Million
Q1 2025 May 14, 2025	BUY	$89.14 - $117.41 $46.5 Million - $61.2 Million	521,512 Added 50.84%	1,547,298 $173 Million
Q4 2024 Feb 14, 2025	BUY	$83.95 - $97.9 $51.6 Million - $60.1 Million	614,059 Added 149.14%	1,025,786 $94.8 Million
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $9.03 Million - $11.4 Million	-135,597 Reduced 24.77%	411,727 $34.5 Million

Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $73 Million - $84.2 Million	-1,155,415 Reduced 67.86%	547,324 $37.6 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $42.6 Million - $52 Million	-595,546 Reduced 25.91%	1,702,739 $125 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $65.1 Million - $73.8 Million	-887,874 Reduced 27.87%	2,298,285 $186 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $14.4 Million - $15.7 Million	194,210 Added 6.49%	3,186,159 $239 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $10.5 Million - $12 Million	-138,750 Reduced 4.43%	2,991,949 $231 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $7.58 Million - $8.64 Million	98,039 Added 3.23%	3,130,699 $260 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $117 Million - $168 Million	1,874,836 Added 161.93%	3,032,660 $260 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $10.3 Million - $11.7 Million	172,593 Added 17.52%	1,157,824 $71.4 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $4.9 Million - $5.52 Million	84,900 Added 9.43%	985,231 $60.9 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $21.3 Million - $26.6 Million	367,100 Added 68.84%	900,331 $53.5 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $5.79 Million - $6.57 Million	-89,200 Reduced 14.33%	533,231 $38.7 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $7.01 Million - $7.57 Million	103,600 Added 19.97%	622,431 $43.5 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $12.2 Million - $13.3 Million	191,655 Added 58.58%	518,831 $35.7 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $7.8 Million - $8.9 Million	130,016 Added 65.94%	327,176 $21.1 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $8.48 Million - $9.66 Million	-149,702 Reduced 43.16%	197,160 $11.5 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $2.44 Million - $3.06 Million	-39,239 Reduced 10.16%	346,862 $21.9 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $10.7 Million - $12.4 Million	-147,800 Reduced 27.68%	386,101 $29.7 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $6.49 Million - $8.32 Million	103,700 Added 24.11%	533,901 $39.9 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $3.56 Million - $3.92 Million	-57,800 Reduced 11.84%	430,201 $28 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $875,140 - $966,000	14,000 Added 2.95%	488,001 $30.9 Million
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $6.76 Million - $7.58 Million	-109,300 Reduced 18.74%	474,001 $32 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $2.24 Million - $2.51 Million	-35,900 Reduced 5.8%	583,301 $37.9 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $11 Million - $14.4 Million	-181,700 Reduced 22.69%	619,201 $38.7 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $1.45 Million - $1.61 Million	-20,400 Reduced 2.48%	800,901 $61.8 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $58 Million - $67.7 Million	-893,914 Reduced 52.12%	821,301 $58.2 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $6.55 Million - $7.98 Million	-89,886 Reduced 4.98%	1,715,215 $129 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $26.3 Million - $30.9 Million	-369,800 Reduced 17.0%	1,805,101 $129 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $157 Million - $186 Million	2,174,901	2,174,901 $177 Million

Others Institutions Holding GILD

# of Institutions

2,414

Shares Held

1.01B

Call Options Held

8.51M

Put Options Held

7.32M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $156B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.

Account

Caisse De Depot Et Placement Du Quebec Gilead Sciences, Inc. Transaction History